Abstract
Pentachlorophenol (PCP) is an antimicrobial agent used chiefly for the preservation of wood. Subchronic oral exposure (14 days) to Technical Grade PCP significantly inhibited the functional activity of female B6C3F1 mouse complement when measured in a microtiter hemolytic assay. When evaluated one day following the final exposure the highest administered dose (100 mg/kg) significantly suppressed the Classical complement pathway, the Spontaneous C1 autoactivation pathway, the Alternate pathway and the level of complement component, C3. Reconstitution studies using C5-deficient serum also demonstrated deleterious effects on this complment component. The Classical pathway was the most sensitive to Technical Grade PCP effects. Animals treated with 100 mg/kg Technical Grade PCP had CH 50 levels 30% of vehicle controls. Animals treated for 14 days and allowed a 15 day recovery period had CH 50 values 36% of control and animals which recovered for 30 days had only 52% of the complement activity of control animals. C3 recovery studies also demonstrated continued suppression on days 15 and 30 post-final exposure. Doses of 10 and 30 mg/kg did not produce the marked effects observed with the highest dose; however, a dose-dependent trend was observed for all responses. Animals treated with 100 mg/kg of EC-7, a PCP preparation with reduced amounts of contaminating dioxins and dibenzofurans, did not demonstrate detrimental effects on the complement system.
Similar content being viewed by others
References
R.L. Johnson, P.J. Ghering, R.J. Kociba andB.A. Schwetz,Chlorinated dibenzodioxins and pentachlorophenol, Environ. Health Persp.5, 171–175 (1973).
J.R. Plimmer,Technical pentachlorphenol: origin and analysis of base-insoluble contaminants, Environ. Health Persp.5, 41–49 (1973).
D.P. Cirelli, Patterns of pentachlorophenol usage in the United States of America—an overview. InPentachlorophenol, pp. 13–18 (Ed.K.R. Rao). Plenum Press, New York 1978.
R.C. Dougherty, Human exposure to pentachlorophenol. InPentachlorophenol, pp. 351–361 (Ed.K.R. Rao). Plenum Publishing Corp., New York 1978.
N.I. Kerkvliet, L. Baecher-Steppan, A.T. Claycomb, A.M. Craig andG.G. Sheggeby,Immunotoxicity of technical pentachlorophenol (PCP-T): depressed humoral immune responses to T-dependent and T-independent antigen stimulation in PCP-T exposed mice, Fundament. Appl. Toxic.2, 90–99 (1982).
N.I. Kerkvliet, L. Baecher-Steppan andJ.A. Schmitz,Immunotoxicity of pentachlorophenol PCP): increased susceptibility to tumor growth in adult mice fed technical PCP-contaminated diets, Toxic. appl. Pharmac.62, 55–64 (1982).
J.H. Exon andL.D. Koller,Effects of chlorinated phenols on immunity in rats, Int. J. Immunopharmac.5, 131–136 (1983).
K.L. White andA.C. Anderson,Measurement of modulation of mouse complement levels in vivo utilizing a microtiter hemolytic assay, Agents and Actions15, 562–568 (1984).
R.J. Ziccardi,The first component of human complement (CI): activation and control, Springer Semin. Immunopathol.6, 213–230 (1983).
H. Van Dijk, P.M. Rademaker andJ.M.N. Willers,Estimation of classical pathway of mouse complement activity by use of sensitized rabbit erythrocytes, J. Immunol. Methods30, 257–268 (1980).
C.W. Dunnett,A multiple comparison procedure for comparing several treatments with a control, J. Am. Stat. Assoc.50, 1096–1121 (1955).
A.R. Jonckheer, inNon-parametric Statistical Methods, pp. 120–123 (EdsM. Hollander andD.A. Wolfe). John Wiley and Sons, New York 1975.
C. Cochrane, H.J. Muller-Eberhard andB.S. Aikin,Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions, J. Immun.205, 55–68 (1970).
H.W. Klemmer, L. Wong, M.S. Sato, E.L. Reichert, R.J. Korsak andM.N. Rashad,Clinical findings in workers exposed to pentachlorophenol, Arch. Environm. Contam. Toxicol.9, 715–725 (1980).
W. Takahashi, E.R. Reichert, G.C. Fung andY. Hokama,Acute phase proteins and pesticide exposure, Life Sci.19, 1645–1652 (1976).
L. Hardell andA. Sandstrom,Case-control study: soft-tissue sarcomas and exposure to phenoxyacetic acids or chlorophenols, Br. J. Cancer39, 711–717 (1979).
L. Hardell, M. Eriksson, P. Lenner andE. Lundgren,Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols, and phenoxy acids: a case control study, Br. J. Cancer43, 169–176 (1981).
A. Bevenue, J. Wilson, L.J. Casarett andH.W. Klemmer,A survey of Pentachlorophenol content of human urine, Bull. Environ. Contam. and Tox,2, 319–332 (1967).
M. Di Rosa, J.P. Giroud andG.A. Willouhby,Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine, J. Path.104, 15–29 (1971).
D.J. Schultz andP.I. Arnold,Cyanate as an inactivator of complement proteins, J. Immun.115, 1558–1565 (1975).
M.M. Azar,C′ inhibition following treatment with various agents. Proc. 42nd Meeting, J. Lab. clin. Med.74, 847–848 (1969).
D.R. Claus, J. Seigel, K. Petras, A.P. Osmand andH. Gewurz,Interactions of C-reactive protein with the first component of human complement, J. Immun.119, 187–192 (1977).
Author information
Authors and Affiliations
Additional information
To whom correspondence should be addressed
Rights and permissions
About this article
Cite this article
White, K.L., Anderson, A.C. Suppression of mouse complement activity by contaminants of technical grade pentachlorophenol. Agents and Actions 16, 385–392 (1985). https://doi.org/10.1007/BF01982877
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01982877